HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

13,17- bis(1- carboxypropionyl)carbamoylethyl- 3- ethenyl- 8- ethoxyiminoethylidene- 7- hydroxy- 2,7,12,18- tetramethyl porphyrin

structure in first source
Also Known As:
13,17-bis(1-carboxypropionyl)carbamoylethyl-3-ethenyl-8-ethoxyiminoethylidene-7-hydroxy-2,7,12,18-tetramethyl porphyrin sodium; PAD-S31; PADS31
Networked: 7 relevant articles (1 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Sakata, Isao: 3 articles (01/2003 - 01/2002)
2. Arai, Tsunenori: 2 articles (11/2005 - 01/2002)
3. Kikuchi, Makoto: 2 articles (11/2005 - 01/2002)
4. Date, Masataka: 2 articles (04/2004 - 01/2003)
5. Fukuchi, Kazuhide: 2 articles (04/2004 - 01/2003)
6. Namiki, Yoshihisa: 2 articles (04/2004 - 01/2003)
7. Ohura, Kiyoshi: 2 articles (04/2004 - 01/2003)
8. Takahashi, Hiroshi: 2 articles (04/2004 - 01/2003)
9. Arai, T: 2 articles (01/2004 - 01/2002)
10. Asanuma, H: 2 articles (01/2004 - 01/2002)

Related Diseases

1. Neoplasms (Cancer)
2. Urinary Bladder Neoplasms (Bladder Cancer)
3. Liver Neoplasms (Liver Cancer)
4. Renal Cell Carcinoma (Grawitz Tumor)
5. Hyperplasia

Related Drugs and Biologics

1. 1-phenyl-3,3-dimethyltriazene (PDT)
2. Cytochromes c (Cytochrome c)
3. Caspases
4. Photosensitizing Agents (Photosensitizers)
5. Therapeutic Uses
6. Tungsten
7. Retinaldehyde (Retinal)
8. chlorin

Related Therapies and Procedures

1. Intravenous Administration
2. Cystoscopes
3. Semiconductor Lasers
4. Photochemotherapy (Photodynamic Therapy)
5. Lasers (Laser)